Biotech

All Articles

Acepodia, Pfizer click together for chemistry-based cell therapy

.Call it an instance of great chemistry: Acepodia, a biotech based upon Nobel Champion science, is a...

Praxis epilepsy drug decreases confiscations in stage 2 litigation

.Praxis Preciseness Medicines has actually scored another midphase win in epilepsy this year, with i...

Three execs resign as Dyne articles blended data for DMD candidate

.After leaving a professional hold numerous years back, Dyne Rehab has uncovered brand-new phase 1/2...

Arrowhead fires off period 3 information in unusual metabolic disease before market clash with Ionis

.Arrowhead Pharmaceuticals has presented its hand ahead of a prospective face-off along with Ionis, ...

Pfizer, Valneva show lyme disease chance reliable for 2nd booster

.Pfizer and Valneva might have about 2 additional years to wait just before they make the initial pe...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Shop with Michelle Benz on the Future of Biotech.

.Let's dive into a discussion with Ayla Ellison, Brutal Biotech Editor-in-Chief and also Michelle Be...

New data show how Bayer's asundexian neglected to prevent movements

.Bayer put on hold the stage 3 test for its element XIa prevention asundexian behind time in 2015 af...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is actually still bented on taking its a number of sclerosis (MS) med tolebrutinib to the FD...

Galapagos' stock up as fund shows intent to form its own evolution

.Galapagos is actually coming under added pressure from financiers. Having actually constructed a 9....

Cell- focused Sana scoops first CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of significant management hirings, firings and a...